Insulin Infusion Protocols for Blood Glucose Management in Critically Ill Patients: A Scoping Review

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

This is a scoping review to summarize Insulin Infusion Protocols(IIPs) for critically ill adult patients, a total of 3 Chinese language and 8 English-language databases were searched for articles published from May 25, 2016, to October 25, 2022. Twenty-one insulin infusion protocols were examined. Most of the insulin infusion protocols were paper protocols. Fourteen glucose management indicators were included in the 21 protocols. The glucose target range for all 21 protocols ranged from 72 to 180 mg/dL (4-10.0 mmol/L). Nurses were primarily responsible for protocol implementation in most protocol development processes. The roles of nurses differed in nurse-led insulin infusion protocols and non-nurse-led insulin infusion protocols. Because insulin infusion protocols are core aspects of blood glucose management guidelines, different population subgroups should also be considered.

Objectives

Map the insulin infusion protocols currently used to manage blood glucose levels in critically ill patients
Identify the content and number of indicators used in each insulin infusion protocol in the glycemic control for critically ill patients
List accountabilities of nurses in insulin infusion protocols in the glucose management for critically ill patients

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity. Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.

Refund Policy

Continuing Education Activities are nonrefundable.